# Central Nervous System (CNS) Agents: Attention Deficit Hyperactivity Disorder Agents

**LENGTH OF AUTHORIZATIONS**: 365 Days

Short Acting products considered separately from Long-Acting products

**PRIOR AUTHORIZATION CRITERIA:**

1. Is there any reason the patient cannot be changed to a medication not requiring prior approval?

    Acceptable reasons include:

    - Allergy to at least **two** medications not requiring prior approval

    - Contraindication to all medications not requiring prior approval

    - History of unacceptable/toxic side effects to at least **two** medications not requiring prior approval

    - Has the patient failed a therapeutic trial of at least **14 days** with at least **two** medications not requiring prior approval?

**STEP THERAPY:**

1. For a drug requiring step therapy, there must have been inadequate clinical response to preferred alternatives, including a trial of no less than **30 days** of at least 8*two preferred** products.

Note: Patients on non-preferred therapies are not required to obtain prior authorization for the use of their product until after June 30th, 2022. Providers may obtain prior authorization before June 30th, 2022.

AR - Dextroamphetamine Solution: a PA is required for patients over 12 years old AR - Methylphenidate Solution: a PA is required for patients over 12 years old

## Attention Deficit Hyperactivity Disorder Agents

| Central Nervous System (CNS) Agents: Attention Deficit Hyperactivity Disorder Agents  |                |
|---------------------------------------------------------------------------------------|----------------|
| PREFERRED                                                                             | NON-PREFERRED  |
| Amphetamine/Dextroamphetamine ER                                                      | Adhansia XR    |
| Amphetamine/Dextroamphetamine IR                                                      | Adzenys ER     |
| Atomoxetine Cap                                                                       | Adzenys XR ODT |
| Clonidine ER                                                                          | Amphetamine Tab|
| Concerta                                                                              | Azstarys       |
| Dexmethylphenidate Tab                                                                | Cotempla XR ODT|
| Dexmethylphenidate ER (generic of Focalin XR)                                         | Daytrana       |
| Dextroamphetamine ER Cap                                                              | Dyanavel XR    |
| Dextroamphetamine Sol AR                                                              | Evekeo ODT     |
| Dextroamphetamine Tab                                                                 | Jornay PM      |
| Focalin XR                                                                            | Methamphetamine|
| Guanfacine ER                                                                         | Methylphenidate Chewable Tab |
| Methylphenidate ER Cap (generic of Metadate CD,  Ritalin LA)                          | Methylphenidate ER (generic of Aptensio XR, Relexxii) |
| Methylphenidate ER Tab (generic of Concerta,  Methylin ER, Ritalin SR)                | Mydayis        |
| Methylphenidate Sol AR                                                                | Vyvanse Chewable Tab         |
| Methylphenidate Tab                                                                   | Zenzedi        |
| Qelbree ST                                                                            |                |
| Quillichew ER                                                                         |                |
| Quillivant XR                                                                         |                |
| Ritalin LA                                                                            |                |
| Vyvanse Cap                                                                           |                |

**Link to Criteria:** [Central Nervous System (CNS) Agents: Attention Deficit Hyperactivity Disorder Agents](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=32)
